Literature DB >> 18180843

[Pathophysiology of obstructive sleep apnea-associated hypertension].

Sergio Rey1, Gloria Valdés, Rodrigo Iturriaga.   

Abstract

There is a well established relationship between the obstructive sleep apnea syndrome and hypertension. Current evidence suggests that the increase in arterial pressure is secondary to an enhanced sympathetic tone through peripheral chemoreflexes triggered by intermittent hypoxic stimulation of the carotid bodies. Chronic intermittent hypoxia would activate renal and systemic vasoactive systems through potentiated hypoxic chemoreflexes. These early changes in autonomic tone can be detected through cardiovascular variability and baroreflex sensitivity analysis. Both are relatively simple and noninvasive techniques. The multiplicity of pathogenic mechanisms in obstructive sleep apnea-associated hypertension emphasizes the need of increasing diagnostic sensitivity to detect and correct this common condition, which significantly increases cardiovascular risk.

Entities:  

Mesh:

Year:  2007        PMID: 18180843     DOI: /S0034-98872007001000016

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

1.  Effect of Telmisartan on local cardiovascular oxidative stress in mouse under chronic intermittent hypoxia condition.

Authors:  Wan-Yu Wang; Wan-Yu Wan; Yi-Ming Zeng; Xiao-Yang Chen; Yi-Xiang Zhang
Journal:  Sleep Breath       Date:  2012-03-25       Impact factor: 2.816

2.  Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity.

Authors:  Wanyu Wang; Ailing Song; Yiming Zeng; Xiaoyang Chen; Yixiang Zhang; Yonghong Shi; Yihua Lin; Wen Luo
Journal:  BMC Cardiovasc Disord       Date:  2018-07-03       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.